`
`V
`
`\
`\\
`
`\\\I\
`
`,wmw
`> thmk
`
`V\\\\\\\&\\\
`
`W\\\\\\H\x
`
`\\\\.x
`\\\\\\\\\\\
`
`\\
`
`\
`
`x\
`
`\\w
`\.x
`
`\
`
`\\\\\\\
`
`
`
`Page 1
`
`
`
`
`
`
`
`
`~.\\‘\1 \\ \\\
` \\\ V\\\\\ me continues
`
`W/é/x
`
`‘
`
`
`~~
`
`1111 1133 {mm 111313111 111113311 111‘ eXCeeded 1113 1131111313.
`
`11
`
`111
`
`1.1ke11'131311ke :'1-:311 1131111311-11.1 131113.111: 13%. 11.3 1:..1" 55.1 1'11
`
`EXCE 1‘1_.1.111111111-:11111111111-:11311<e 13.11133 C11:"113C 151131111111331;
`
`1'11 ENA'
`
`’1131‘11111113’11. 1111111111111311 13113131131111113111 1311111111111 1311Cé< 1.13 C11'1‘1111’111
`.2
`
`
`C1‘1’e1 111e1’ea1.‘ 13:11 11113111111111.1113 13% 1111311111111 1: 1131.311C1
`
`1'11
`
`11131-311111} 11119.111 31111113.1"1.111311111: 1311111331,
`
`(“1131113111311 811131131113,
`
`
`
`1'11
`
`1
`
`11
`
`1:113:11, 11311311: and finish 1eC1 11113 5111311111111.
`
`811111112013 1131 111:~"1’11 1351:111311 151% 111111111131 $115.19. 131' 111131 1113 111131 E1311.
`
`1111111111111 1311.11 113C1eaeC1 11.11,. 151161 13133 311331 1.11 1.3111111.
`
`13111111131911 net 1111;011:132 13113111111311. (+10% CC111'1311311111111113131
`
`15.111111e C1 1131111111113 111313113111 1:.1 311131111 (11-1: "1s~
`
`‘11.: 3113‘.13.111131111311113: 11111 131111 gzve
`
`1:01'1111'1er1cs31 11131 we
`
`have 11113 1111111 131113.?1116‘3 3353111311111, 11113 11:11:11 01331111313111311 1‘1: 11C1‘11
`
`1111111 111111
`
`:1311111 11113. 111.1111: 1.11 111.1. 1:1 113111.113: (11111311111311 :1 111111
`
`
`
`2013 targets
`0 Net revenue growth of 5-
`constant exchange rates,
`RB Pharmaceuticals.
`
`0 Maintain operating marg
`excluding RB Pharmaceut
`
`For 2012 our health and hy
`revenues were 68% of our
`
`Africa (RUMEA), Europe and North An
`
`geographic portfolio (67%
`and LAPAC and RUMEA we
`
`our core3 geographic portfo
`in 2011). This strategic resh
`our portfolio is ahead of sc
`and we have accelerated tW
`medium-term KPls from 201
`
`1 Latin America, North Asia, South East
`Australia and New Zealand (LAPAC), R
`Middle East, North Africa, Turkey and
`
`Page 2
`
`
`
`.wewh
`swam“w53Nexiansa‘.
`
`
`fund“)?
`
`
`mi,
`
`3
`
`CATEGGRY K?!
`
`R
`
`ER. PHSXRM
`
`.63:
`
`.9.
`
`EUTECALS
`
`$3
`
`\\
`
`\\\\\\\_
`
`memfi
`trimuh.
`wwnndm£5,33v
`“51:;
`
`
`wwwfh
`amimmym:
`iflywHWM;
`,.
`
`V104
`
`hmfivm
`.raf.n~
`fins!a\h
`
`53.runa$3.:
`ammnr
`
`\
`
`\oV\\\\
`
`fi“
`
`\3V\\\~
`
`\\§
`
`TALENTEL‘S, GLQBAL EMFLQYEES
`
`k
`
`Page 3
`
`
`
`
`
`
`
`
`
`U953
`
`RAND F
`
`CER'E'FGLEO, MARKE i'
`
`C
`
`\Jxn-
`
`H.
`
`\’u
`
`
`
`“u..w
`
`D...
`
`Ream
`
`is ewfiutfi
`
`mg
`
`RB F’harmaceu'tica
`
`55E
`
`.1
`
`2Q
`
`Pharma
`
`f.
`
`eutiuais
`."\
`
`\my.
`
`.3
`
`Page 4
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ion of this report is made from FSC certified sustainable forest stocks.
`
`Fresh, Finish,
`arpic, Harpic
`,
`o—Touch, Nugget,
`Power Plus, Quantum,
`oil, Spray ‘17 Wash, Strepsils,
`eat; Veja, Woo/its as well as
`
`'rkroom vme.workroom.co.uk
`
`:.- p rt is produced using a Elemental Chlorine Free (ECF)
`th FSC (Forest Stewardship Council) Mix Credit certified pulp
`‘orests with a verifiable chain of custody. The envelope used for
`
`Page 5
`
`